Unlock AI-driven, actionable R&D insights for your next breakthrough.

L-Methionine Compatibility: Comprehensive Analysis Of Biochemical Interactions, Formulation Strategies, And Industrial Applications

NOV 17, 202666 MINS READ

Want An AI Powered Material Expert?
Here's Patsnap Eureka Materials!
L-Methionine compatibility encompasses the biochemical, physicochemical, and formulation-related interactions of this essential sulfur-containing amino acid with biological systems, excipients, processing conditions, and co-administered substances. As a critical methyl donor precursor and building block in protein synthesis, L-Methionine exhibits specific compatibility requirements that directly impact its therapeutic efficacy, fermentation yield, feed additive performance, and pharmaceutical formulation stability. Understanding these compatibility parameters is essential for optimizing production processes, ensuring bioavailability, and preventing degradation or adverse interactions in diverse applications ranging from animal nutrition to biopharmaceutical manufacturing.
Want to know more material grades? Try Patsnap Eureka Material.

Stereochemical Specificity And Enantiomeric Compatibility Of L-Methionine

The absolute requirement for the L-enantiomer of methionine in biological systems represents a fundamental compatibility constraint that distinguishes this amino acid from racemic mixtures 1. The L-isomeric form is essential because only L-Methionine can be efficiently converted to S-adenosylmethionine (SAM), the universal methyl group donor in transmethylation reactions 1. This conversion occurs via the methionine adenosyltransferase enzyme system and requires the presence of adenosine triphosphate, magnesium ions, and potassium ions as cofactors 1.

The use of D,L-methionine mixtures presents significant compatibility issues in biological applications. D-Methionine exhibits inhibitory effects on L-methionine metabolism, potentially competing for binding sites on S-adenosyltransferase enzymes 8. This competitive inhibition reduces the efficiency of SAM synthesis and may compromise the methylation capacity that is critical for immune function and numerous biochemical processes 1. In healthy individuals, the physiological ratio of SAM to S-adenosylhomocysteine (SAH) is approximately 20:1, but this ratio can decline to 5:1 in severe immune deficiency states 1. Therefore, formulations intended for therapeutic or nutritional applications must ensure enantiomeric purity to maintain optimal biochemical compatibility.

Chemical synthesis methods, such as hydrolysis of 5-(β-methylmercaptoethyl)-hydantoin, inherently produce racemic D,L-mixtures 26. Consequently, separation processes or preferential biological production methods are required to obtain the L-enantiomer with sufficient purity for applications demanding high biocompatibility 8. Protein hydrolysis and amino acid separation, or fermentation-based biosynthesis using engineered microorganisms, represent alternative production routes that yield exclusively the L-form 234.

Biochemical Compatibility: Enzymatic Pathways And Metabolic Integration

Methionine Biosynthesis Pathways And Enzyme Compatibility

L-Methionine biosynthesis in microorganisms involves multiple enzymatic steps, each with specific substrate and cofactor compatibility requirements. Two primary enzymatic routes exist for the final step of methionine synthesis: direct sulfhydrylation and transsulfuration 26.

Direct sulfhydrylation utilizes O-acylhomoserine (O-acetylhomoserine or O-succinylhomoserine) and hydrogen sulfide or methyl mercaptan as substrates. Enzymes such as O-acetylhomoserine sulfhydrylase, encoded by genes like metY or metZ, catalyze this reaction 2611. The metZ gene product has been identified as particularly effective in industrial L-methionine production, as it avoids the feedback inhibition issues associated with metY and the by-product formation problems of the metB-encoded transsulfuration pathway 2611. Compatibility with methyl mercaptan or its salts is critical; enzymatic processes using proteins from Corynebacterium humireducens and related species demonstrate high substrate specificity and reduced acetate by-product formation 7.

Transsulfuration pathways employ O-acylhomoserine and cysteine as substrates, with cystathionine-γ-synthase (MetB, EC 2.5.1.48) catalyzing the reaction 9. However, MetB exhibits poor compatibility with industrial-scale production due to significant by-product accumulation and the formation of undesired compounds such as homolanthionine 9. Reducing or eliminating MetB activity, while enhancing alternative pathways, improves overall process compatibility and product purity 9.

Cofactor And Additive Compatibility For Enhanced Bioavailability

L-Methionine's metabolic conversion to SAM and subsequent methylation reactions depend on the availability of specific cofactors. Formulations designed to enhance methylation capacity often incorporate biologically acceptable magnesium compounds, folic acid, vitamin B6 (pyridoxine and vitamers), and vitamin B12 (cobalamin and vitamers) 8.

Magnesium is essential for the methionine adenosyltransferase enzyme system. Biologically acceptable magnesium salts (e.g., magnesium chloride, magnesium carbonate) or chelates are compatible with L-methionine at mass ratios of approximately 1:2 to 1:6 (magnesium compound to L-methionine) 8. Magnesium carbonate is preferred in capsule formulations due to its non-hygroscopic properties and favorable flow characteristics 8.

Folic acid supports the remethylation of homocysteine back to methionine, thereby maintaining methionine pools and preventing homocysteine accumulation. Compatible formulations include folic acid at mass ratios of 1:75 to 1:8000 relative to L-methionine, supplying 0.7 µg to 0.3 mg per kilogram body mass per day 8. Vitamin B6 and B12 similarly support enzymatic steps in methionine and homocysteine metabolism, enhancing overall compatibility with physiological pathways 8.

Physicochemical Compatibility: Stability, Solubility, And Formulation Considerations

Chemical Stability And Environmental Compatibility

L-Methionine exhibits good chemical stability under neutral to slightly alkaline conditions but is susceptible to oxidation and degradation under extreme pH, high temperature, or in the presence of strong oxidizing agents. The sulfur-containing side chain (methylthio group) is particularly vulnerable to oxidative modification, which can lead to the formation of methionine sulfoxide or methionine sulfone, both of which lack biological activity.

Compatibility with formulation excipients is critical. L-Methionine is compatible with most pharmaceutical excipients, including cellulose derivatives, starches, and common disintegrants, provided that moisture content is controlled. Hygroscopic excipients or high-humidity storage conditions can promote hydrolysis or oxidation, reducing product stability 8. Magnesium stearate and other flow agents are compatible and commonly used to improve powder flow characteristics in capsule or tablet formulations 8.

Solubility And Dissolution Compatibility

L-Methionine is moderately soluble in water (approximately 56 g/L at 25°C) and exhibits pH-dependent solubility, with enhanced dissolution at acidic or alkaline pH due to protonation or deprotonation of the amino and carboxyl groups. This solubility profile is compatible with oral dosage forms and liquid feed supplements, but formulation strategies must account for potential precipitation or crystallization during storage or upon dilution.

In fermentation processes, L-methionine solubility and compatibility with culture media components are essential. The amino acid must remain in solution at concentrations sufficient for microbial uptake and secretion, typically in the range of 5–50 g/L depending on the production strain and process conditions 4510. Compatibility with carbon sources (glucose, glycerol), nitrogen sources (ammonium salts, yeast extract), and mineral supplements (phosphates, sulfates) must be optimized to prevent precipitation or nutrient imbalances 10.

Microbial Production Compatibility: Strain Engineering And Fermentation Conditions

Genetic Compatibility And Metabolic Engineering

Modern L-methionine production relies on genetically engineered microorganisms, primarily from the families Enterobacteriaceae (e.g., Escherichia coli, Pantoea) and Corynebacteriaceae (e.g., Corynebacterium glutamicum) 4512. Compatibility of introduced genes with the host's metabolic network is paramount for achieving high yields.

Key genetic modifications include:

  • Deletion of metJ gene: The metJ gene encodes a transcriptional repressor of the methionine regulon. Deletion of metJ derepresses methionine biosynthesis genes, enhancing flux through the pathway 512.
  • Desensitization of MetA (homoserine O-succinyltransferase): Mutations that reduce feedback inhibition by methionine and SAM improve pathway flux and are compatible with high-level methionine production 512.
  • Introduction of metZ gene: The metZ gene from foreign sources (e.g., Corynebacterium species) encodes an O-acetylhomoserine sulfhydrylase with superior activity and reduced feedback inhibition compared to native metY or metB enzymes 2611. Strains expressing metZ exhibit enhanced compatibility with industrial fermentation conditions and achieve methionine titers exceeding 20 g/L 211.
  • Disruption or attenuation of metB gene: Reducing MetB activity prevents homolanthionine accumulation and by-product formation, improving product purity and process compatibility 9.
  • Overexpression of rarD gene: The rarD gene product enhances stress tolerance and metabolic robustness in Pantoea strains, improving compatibility with high-density fermentation and nutrient limitation conditions 512.

Fermentation Conditions And Process Compatibility

Optimal fermentation conditions for L-methionine production typically include:

  • Temperature: 25–45°C, with 30–37°C being most common for E. coli and Pantoea strains 10.
  • pH: 6.5–9.0, with pH 7.0–7.5 preferred to balance enzyme activity, substrate solubility, and product stability 10.
  • Dissolved oxygen: Adequate aeration is required for oxidative metabolism and SAM synthesis, but excessive oxygen can promote methionine oxidation.
  • Carbon source: Glucose, glycerol, or other carbohydrates at concentrations of 20–100 g/L, with fed-batch strategies to prevent overflow metabolism and acetate accumulation 410.
  • Nitrogen source: Ammonium sulfate, ammonium chloride, or organic nitrogen (yeast extract, peptone) at concentrations providing C:N ratios of 5:1 to 10:1 10.
  • Sulfur source: Sodium sulfate, sodium thiosulfate, or methyl mercaptan, with compatibility depending on the enzymatic pathway (direct sulfhydrylation vs. transsulfuration) 3710.

Compatibility with downstream processing is also critical. L-Methionine is typically recovered by crystallization, ion-exchange chromatography, or membrane filtration, with purity targets of 95% or higher for pharmaceutical and feed applications 512.

Pharmaceutical And Nutraceutical Formulation Compatibility

Compatibility With Excipients And Delivery Systems

L-Methionine is formulated into tablets, capsules, powders, and liquid solutions for oral administration. Compatibility with common pharmaceutical excipients has been extensively studied:

  • Binders: Hydroxypropyl methylcellulose (HPMC), polyvinylpyrrolidone (PVP), and starch are compatible and do not interact adversely with L-methionine 8.
  • Disintegrants: Croscarmellose sodium, sodium starch glycolate, and crospovidone are compatible and facilitate rapid tablet disintegration and dissolution.
  • Lubricants: Magnesium stearate is widely used and compatible, though excessive levels may reduce dissolution rate 8.
  • Fillers: Lactose, microcrystalline cellulose, and dicalcium phosphate are compatible, but lactose-intolerant formulations may substitute with mannitol or sorbitol.
  • Coatings: Enteric coatings (e.g., Eudragit polymers) can be applied to protect L-methionine from gastric degradation and target release in the small intestine, enhancing bioavailability.

Liquid formulations require pH adjustment (typically pH 5.0–7.0) and may include antioxidants (e.g., ascorbic acid, sodium metabisulfite) to prevent oxidation. Compatibility with preservatives (e.g., parabens, sorbates) and flavoring agents must be evaluated to ensure stability over the product shelf life.

Compatibility With Co-Administered Nutrients And Drugs

L-Methionine is often co-administered with other amino acids, vitamins, and minerals in multivitamin or amino acid supplements. Compatibility considerations include:

  • Other amino acids: L-Methionine is compatible with most amino acids, but high concentrations of cysteine or homocysteine may shift metabolic equilibria and affect methionine utilization.
  • Vitamins: As noted, folic acid, B6, and B12 enhance methionine metabolism and are highly compatible 8. Fat-soluble vitamins (A, D, E, K) do not interact adversely.
  • Minerals: Magnesium, zinc, and selenium are compatible and may support methionine-dependent enzymes. However, high levels of copper or iron may catalyze oxidation of the methylthio group, necessitating antioxidant inclusion.
  • Drugs: L-Methionine may interact with certain medications. For example, it can enhance the hepatoprotective effects of acetylcysteine but may interfere with levodopa absorption due to competition for amino acid transporters. Compatibility with specific drug regimens should be evaluated on a case-by-case basis.

Feed Additive Compatibility: Animal Nutrition And Performance

Compatibility With Feed Ingredients And Processing

L-Methionine is a critical limiting amino acid in poultry, swine, and aquaculture feeds. Its compatibility with feed ingredients and processing conditions is essential for maintaining nutritional value and animal performance.

  • Protein sources: L-Methionine is compatible with soybean meal, corn gluten meal, fishmeal, and other protein concentrates. Supplementation corrects methionine deficiency and improves feed conversion ratios.
  • Carbohydrates and fats: L-Methionine does not interact adversely with cereal grains (corn, wheat, barley) or lipid sources (soybean oil, fish oil).
  • Vitamins and minerals: L-Methionine is compatible with standard vitamin and mineral premixes used in animal feeds. Choline, a methyl donor, is often co-supplemented and is fully compatible 1.
  • Pelleting and extrusion: L-Methionine is stable under typical feed processing conditions (temperatures up to 80–90°C for short durations), but prolonged exposure to high heat (>100°C) or moisture can cause degradation. Coated or encapsulated forms improve stability during pelleting and storage.

Bioavailability And Metabolic Compatibility In Animals

The bioavailability of L-methionine in animal feeds is high (>90%) when provided in free form or as dipeptides. Compatibility with the animal's digestive physiology and metabolic pathways ensures efficient absorption and utilization:

  • Absorption: L-Methionine is absorbed in the small intestine via amino acid transporters (e.g., system B⁰, system L). Compatibility with other amino acids for transporter binding is generally favorable, though high levels of leucine or phenylalanine may compete.
  • Metabolism: Once absorbed, L-methionine is incorporated into proteins or converted to SAM for methylation reactions. Compatibility with hepatic and muscle metabolic pathways is excellent, with minimal risk of toxicity at nutritional doses (0.3–0.6% of diet dry matter).
  • Excretion: Excess methionine is catabolized to homocysteine, cysteine, and ultimately sulfate, which is excreted in urine. This metabolic compatibility prevents accumulation and toxicity.

Industrial And Biotechnological Compatibility

Compatibility With Enzymatic And Chemical Synthesis Processes

L-Methionine can be synthesized enzymatically from precursors such as O-acetyl-L-homoserine and methyl mercaptan using recombin

OrgApplication ScenariosProduct/ProjectTechnical Outcomes
BIOMOX PHARMACEUTICALSTherapeutic applications for immune deficiency conditions requiring enhanced methylation capacity and immune response activation in human and animal subjects.L-Methionine Immune Support FormulationEnhances methylation capacity by converting L-methionine to S-adenosylmethionine (SAM), increasing SAM:SAH ratio from 5:1 to 20:1 in immune-deficient states, with magnesium, folic acid, and B-vitamins as cofactors.
CJ CHEILJEDANG CORPORATIONIndustrial-scale fermentation production of high-purity L-methionine for feed additives and pharmaceutical applications using genetically engineered Corynebacterium strains.MetZ-Based L-Methionine Fermentation SystemUtilizes foreign metZ gene encoding O-acetylhomoserine sulfhydrylase to achieve L-methionine titers exceeding 20 g/L, avoiding feedback inhibition and by-product formation associated with metY and metB pathways.
AJINOMOTO CO. INC.High-density fermentation systems for cost-effective production of L-methionine in animal nutrition and biopharmaceutical manufacturing under nutrient-limited conditions.Pantoea-Based L-Methionine Production PlatformEmploys rarD gene overexpression in Pantoea strains with metJ deletion and desensitized MetA enzyme, achieving L-methionine purity of 95% or higher with enhanced stress tolerance and metabolic robustness.
ARKEMA FRANCESustainable biocatalytic production of pharmaceutical-grade L-methionine for applications requiring high enantiomeric purity and compliance with green chemistry principles.Enzymatic L-Methionine Synthesis ProcessProduces exclusively L-enantiomer through enzymatic reaction of O-acetyl-L-homoserine with methyl mercaptan, eliminating D-isomer contamination inherent in chemical synthesis and reducing acetate by-product formation.
BASF AGOptimized microbial fermentation for high-purity L-methionine production in feed additives and pharmaceutical formulations requiring minimal impurities.Homolanthionine-Reduced L-Methionine Production SystemReduces MetB cystathionine-γ-synthase activity to prevent homolanthionine accumulation and by-product formation, improving L-methionine yield and product purity in fermentation processes.
Reference
  • Composition containing l-methionine and additives for use as a medicament
    PatentInactiveIL103152A
    View detail
  • L-methionine producing microorganism to which protein encoded by foreign metz gene is introduced and method for producing l-methionine using same
    PatentPendingIN202217028995A
    View detail
  • Method for producing l-methionine
    PatentActiveSG11201802624YA
    View detail
If you want to get more related content, you can try Eureka.

Discover Patsnap Eureka Materials: AI Agents Built for Materials Research & Innovation

From alloy design and polymer analysis to structure search and synthesis pathways, Patsnap Eureka Materials empowers you to explore, model, and validate material technologies faster than ever—powered by real-time data, expert-level insights, and patent-backed intelligence.

Discover Patsnap Eureka today and turn complex materials research into clear, data-driven innovation!

Group 1912057372 (1).pngFrame 1912060467.png